作者: Masashi Mizokami , Tatsunori Nakano , Etsuro Orito
DOI: 10.1007/978-4-431-68488-6_6
关键词:
摘要: Chronic hepatitis C is a common disease worldwide and major cause of chronic liver in many countries. However, the current standard therapy with interferon (IFN) rather unsatisfactory [1–3]. Therefore, search for additional therapies needs to be pursued. Molecular evolutionary analysis has been applied numerous studies virus (HCV) given informative suggestions. it not yielded helpful information developing effective antiviral drugs against HCV infection.